Pharmacy Is Right For Me
JUNE 30, 2023
Join us as we explore the inspiring journey of Cayden Miller, a passionate pharmacy graduate from Southern Illinois University at Edwardsville School of Pharmacy. Cayden’s experience as a member of the LGBTQIA+ community has shaped his path in pharmacy, driving him to become an advocate for diversity, equity, and inclusion (DEI) within the profession.
Fierce Pharma
JUNE 30, 2023
A former statistician at Pfizer and his associate have been charged (PDF) with insider trading, using advance inform | A former statistician at Pfizer and his associate have been charged with insider trading, using advance information to make more than $350,000 from stock purchases that they executed one day before the company made trial results public for COVID-19 blockbuster Paxlovid.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JUNE 30, 2023
As one of the most trusted health care professionals, pharmacists play a vital role in debunking medication myths by providing patients with accurate information to make positive decisions regarding their health.
STAT
JUNE 30, 2023
The five cases of malaria diagnosed in Florida and Texas in recent weeks — the first cases of local transmission in the United States in 20 years — have worried some residents and led state and federal officials to issue public alerts about the cluster of infections. But scientists and public health officials, while advising people in the affected areas to take precautions, say there is little cause for alarm, for several reasons: The number of cases is very low; there are easy, lo
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JUNE 30, 2023
Findings suggest that psychometric tests used for The Respiratory Infection Intensity and Impact Questionnaire provide reliable, construct validity, and responsive evidence to detect onset symptoms of RSV.
Drug Topics
JUNE 30, 2023
With high-deductible health plans on the rise, pharmacists need a cash pricing plan now. Artificial intelligence, or AI, could be the answer. Learn more about this innovative technology and how it could impact your bottom line.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JUNE 30, 2023
Pat Furlong was sitting in her home office in Middletown, Ohio, last Thursday, refreshing a Food and Drug Administration web page ad nauseam, when the phone rang. She answered and burst into tears. The FDA had just approved the first gene therapy for Duchenne muscular dystrophy, her friend and the therapy’s architect, Jerry Mendell, told her.
Pharmacy Times
JUNE 30, 2023
Independent pharmacies can provide more personalized care to individuals with behavioral health conditions or intellectual and developmental disabilities.
Drug Topics
JUNE 30, 2023
The acceptance comes 5 days after the agency approved delandistrogene moxeparvovec-rokl to treat ambulatory pediatric DMD patients aged 4 to 5 years.
Pharmacy Times
JUNE 30, 2023
Galcanezumab-gnlm (Emgality; Eli Lilly and Company) did not demonstrate superiority to rimegepant orally disintegrating tablet (Nurtec ODT) on the percentage of individuals achieving a 50% or greater reduction in monthly migraine headache days.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
JUNE 30, 2023
The U.S. | The SCOTUS rulings Thursday will have far-reaching consequences for the healthcare industry and its collective efforts to address diversity in the workforce and health inequities among underrepresented groups.
Pharmacy Times
JUNE 30, 2023
Until now, studies examining the relationship between testosterone and adverse cardiovascular events in men with hypogonadism were limited and inconsistent.
Drug Topics
JUNE 30, 2023
Disadvantaged groups are feeling the sting of health care costs—so much so that many are foregoing health care because they can’t pay for it.
European Pharmaceutical Review
JUNE 30, 2023
A collaborative approach to advancing adoption of RMMs EPR ’s Caroline Peachey explores collaborative efforts to accelerate validation and adoption of rapid microbial methods across the pharmaceutical industry. The power of rapid methods for fungal ID By leveraging rapid identification techniques, pharmaceutical facilities can enhance their ability to detect and mitigate fungal contamination, safeguarding product quality and patient safety.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Topics
JUNE 30, 2023
The revised guidance includes clarified aspects of the negotiation process and additional opportunities for engagement during the process.
Pharmaceutical Technology
JUNE 30, 2023
Health Canada has approved Endo International’s Xcopri as adjunctive therapy in the management of partial-onset seizures in adults with epilepsy.
STAT
JUNE 30, 2023
Bright Health Group has agreed to sell its Medicare Advantage plans to its publicly traded peer Molina Healthcare. Regulators must approve the deal. But the pending sale of its Medicare Advantage business means the financially distressed Bright has exited the health insurance market that the company was founded on. It will solely operate roughly 70 physician clinics located in California, Texas, and Florida.
The Thyroid Pharmacist
JUNE 30, 2023
Have you heard of low dose naltrexone, or LDN? Since the beginning of my Hashimoto’s journey, this medication has been on my radar – and in recent years, I have learned so much more about it. In 2015, I conducted a survey of over 2000 readers with Hashimoto’s , asking for the most helpful interventions in their health journeys. One reader wrote: “Low Dose Naltrexone changed my life for the better.
STAT
JUNE 30, 2023
After having a day to read through the Supreme Court’s decision on affirmative action , some medical school and educational leaders are more hopeful that a path exists for them to diversify future classes and the health care workforce as they scramble to understand its impact on the next admissions cycle and the class of 2024. Several told STAT they saw the court’s ruling as explicitly endorsing the use of “holistic review,” a tool used increasingly by medical, dental
Fierce Pharma
JUNE 30, 2023
The Securities and Exchange Commission (SEC) has revealed insider trading charges against five—including former Alexion Vice President | The SEC has revealed insider trading charges against five—including former Alexion vice president Joseph Dupont and a Massachusetts police chief—who allegedly took advantage of prior knowledge of Alexion’s 2020 acquisition of Portola Pharmaceuticals.
STAT
JUNE 30, 2023
The past several months have been grim for health in the U.S. In December, the Centers for Disease Control and Prevention reported the lowest life expectancy in more than 25 years. Another CDC report in March showed that maternal mortality was on the rise. Yet another report in March found that even children are dying at higher rates than ever before.
Hospital Pharmacy Europe
JUNE 30, 2023
The number of training places available for pharmacists in England will increase by 50% to almost 5,000 by 2031/32, and new routes for education and progression will be offered, the new NHS Long Term Workforce Plan reveals. The much-anticipated and long-overdue plan details a programme of ambitious incremental growth for pharmacist education and training , which will see an initial rise in training places of 15% in 2026/27, followed by a 29% increase to around 4,300 by 2028/29, before reaching t
pharmaphorum
JUNE 30, 2023
Editor in Chief Jonah Comstock speaks with Mark Reisenauer, president, US Commercial at Astellas. Mark gives an update on some of Astellas’s abstracts at the show, including the trials in gastric cancer, bladder cancer, and head and neck cancer.
The Checkup by Singlecare
JUNE 30, 2023
You’ve probably experienced bloating and fluid retention at some point. Excess water and sodium retention can happen if you consume a large amount of salt. But It can also occur due to certain medical conditions , like liver, heart, or kidney problems. If you have fluid retention caused by health problems, your provider may prescribe furosemide. Also known by the brand name Lasix , the diuretic is commonly used to decrease edema (fluid retention) in patients with chronic health conditions.
Fierce Pharma
JUNE 30, 2023
Novartis is passing off the dry eye disease drop Xiidra to eye health specialist Bausch + Lomb in a $2.5 billion deal, another step in the company's overhaul as it focuses on five core areas. | Novartis is passing off the dry eye disease drop Xiidra to eye health specialist Bausch + Lomb in a $2.5 billion deal, another step in the company's overhaul as it focuses on five core areas.
STAT
JUNE 30, 2023
In 1983, I flew home from college to be with my mother as she woke up from a mastectomy. She opted out of breast reconstruction, choosing to “go flat” instead. When I was diagnosed with breast cancer in 2017 and had bilateral mastectomies , I had more reconstruction options than my mother did.
Pharmacy Times
JUNE 30, 2023
Plant-based insulin contains all 3 peptides that are found in insulin naturally produced by the body.
Fierce Pharma
JUNE 30, 2023
Shionogi will pay $100 million upfront to purchase an infectious disease company. Takeda unveiled more data to back its enzyme replacement therapy for a rare heart disease. | Shionogi will pay $100 million upfront to purchase an infectious disease company. Takeda unveiled more data to back its enzyme replacement therapy for a rare heart disease. AbbVie's BTK patent infringement lawsuit against BeiGene may have merit, according to a patent expert.
European Pharmaceutical Review
JUNE 30, 2023
Demand for process analytical technology ( PAT ) is being driven by the growing adoption of automation and digitalisation in sectors such as pharmaceutical industry, a report by Market.us has found. With PAT being widely used in pharma, rising R&D expenses are anticipated to boost demand for these technologies. Growth and limitations in the global PAT market The PAT market is expected to grow $10.6 billion in 2032, the report suggested.
Fierce Pharma
JUNE 30, 2023
Boehringer Ingelheim's Cyltezo stands out from the crowd because it's the only Humira biosimilar to carry an interchangeability designation.
Drug Store News
JUNE 30, 2023
A multi-month celebration is rooted in connecting families for a better future and designed to thank team members, customers and communities, the company said.
Fierce Pharma
JUNE 30, 2023
Shareholders in Alkermes have quelled Sarissa Capital, reelecting seven board members and rejecting three nominees from the activist investor.
Drug Store News
JUNE 30, 2023
Following the recent elimination of more than 500 roles, Walgreens Boots Alliance is planning to close 300 locations in the U.K. and 150 in the United States.
European Pharmaceutical Review
JUNE 30, 2023
The limulus amebocyte lysate (LAL) assay for bacterial endotoxin testing (BET) is currently facing some of its greatest challenges as a reagent in the pharmaceutical industry, according a paper published in the Journal of Applied Bioanalysis. The author highlighted key obstacles and offered potential opportunities for the future. Challenges The first current challenge the author discussed was the supply of materials and conservation of resources for endotoxin testing.
Expert insights. Personalized for you.
246 
Let's personalize your content